相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNA-binding, photocleavage, cytotoxicity in vitro, apoptosis and cell cycle arrest studies of symmetric ruthenium(II) complexes
Yang-Yin Xie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
Jakob Kljun et al.
INORGANIC CHEMISTRY (2013)
Metal-drug synergy: new ruthenium(II) complexes of ketoconazole are highly active against Leishmania major and Trypanosoma cruzi and nontoxic to human or murine normal cells
Eva Iniguez et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
The induction of mitochondria-mediated apoptosis in cancer cells by ruthenium(II) asymmetric complexes
Chen Qian et al.
METALLOMICS (2013)
Searching for New Chemotherapies for Tropical Diseases: Ruthenium-Clotrimazole Complexes Display High in Vitro Activity against Leishmania major and Trypanosoma cruzi and Low Toxicity toward Normal Mammalian Cells
Alberto Martinez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
New Ruthenium(II)-Letrozole Complexes as Anticancer Therapeutics
Annie Castonguay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Cytotoxic effects of two organotin compounds and their mode of inflicting cell death on four mammalian cancer cells
Armando Varela-Ramirez et al.
CELL BIOLOGY AND TOXICOLOGY (2011)
Cell Cycle Arrest, Cytotoxicity, Apoptosis, DNA-Binding, Photocleavage, and Antioxidant Activity of Octahedral Ruthenium(II) Complexes
Hong-Liang Huang et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2011)
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
Jochen H. Lorch et al.
LANCET ONCOLOGY (2011)
Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells
Alberto Martinez et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Synthesis, Characterization, and in vitro Antimalarial and Antitumor Activity of New Ruthenium(II) Complexes of Chloroquine
Chandima S. K. Rajapakse et al.
INORGANIC CHEMISTRY (2009)
Synthesis of Apoptosis-Inducing Iminophosphorane Organogold(III) Complexes and Study of Their Interactions with Biomolecular Targets
Neha Shaik et al.
INORGANIC CHEMISTRY (2009)
Synthesis, characterization, DNA interaction studies and anticancer activity of platinum-clotrimazole complexes
Maribel Navarro et al.
TRANSITION METAL CHEMISTRY (2009)
KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
Christian G. Hartinger et al.
CHEMISTRY & BIODIVERSITY (2008)
Antitumour metal compounds: more than theme and variations
Michael A. Jakupec et al.
DALTON TRANSACTIONS (2008)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: A new strategy that might lead to improved activity
Ioannis Bratsos et al.
INORGANIC CHEMISTRY (2007)
Ruthenium anticancer compounds: Challenges and expectations
Ioannis Bratsos et al.
CHIMIA (2007)
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: Arene loss, aquation, and cancer cell cytotoxicity
Sarah J. Dougan et al.
INORGANIC CHEMISTRY (2006)
IKKβ programs to turn on the GADD45α-MKK4-JNK apoptotic cascade specifically via p50 NF-κB in arsenite response
Lun Song et al.
JOURNAL OF CELL BIOLOGY (2006)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Synthesis and characterization of new palladium-clotrimazole and palladium-chloroquine complexes showing cytotoxicity for tumor cell lines in vitro
M Navarro et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes
C Scolaro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells
SL Fink et al.
INFECTION AND IMMUNITY (2005)
Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide
FY Wang et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2005)
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
S Kapitza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
NC381, a novel anticancer agent, arrests the cell cycle in G0-G1 and inhibits lung tumor cell growth in vitro and in vivo
MY Cao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Tumor apoptosis induced by Ruthenium(II)-ketoconazole is enhanced in nonsusceptible carcinoma by monoclonal antibody to EGF receptor
MS Rieber et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media
O Novakova et al.
BIOCHEMISTRY (2003)
Antianglogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers
L Morbidelli et al.
BRITISH JOURNAL OF CANCER (2003)
Docetaxel and ketoconazole in advanced hormone-refractory prostate carcinoma - A phase I and pharmacokinetic study
PJ Van Veldhuizen et al.
CANCER (2003)
The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway
B Sanna et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis
C Ito et al.
LEUKEMIA (2002)
In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
RE Aird et al.
BRITISH JOURNAL OF CANCER (2002)
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A
G Sava et al.
EUROPEAN JOURNAL OF CANCER (2002)
Inhibition of cancer cell growth by ruthenium(II) arene complexes
RE Morris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Induction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures
J Borlak et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Cytochrome P450 mono-oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat
T Thum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1:: A potential immunosuppressant
H Wulff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
DNA as a possible target for antitumor ruthenium(111) complexes - A spectroscopic and molecular biology study of the interactions of two representative antineoplastic ruthenium(111) complexes with DNA
E Gallori et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
分享论文
